OPRX News and Press, OptimizeRx Corporation From 07/20/22

Gainers: Rhythm Pharmaceuticals ( RYTM ) +20% . Allakos ( ALLK ) +14% . Senti Biosciences ( SNTI ) +13% . Arcturus Therapeutics ( ARCT ) +7% . Verve Therapeutics ( VERV ) +5% . Losers: Vascular Biogenics ( VBLT ) -78%...

Large and growing TAM with industry tailwinds like digitalization supporting growth in demand for OptimizeRx's solutions. Highly scalable operating model with more than sufficient network capacity to facilitate growth in the near term. OptimizeRx has a strong network of large cust...

ROCHESTER, Mich., June 23, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced a major extension of its omni-channel platform re...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Small-cap stocks have a market capitalization of between $300 million to $2 billion. These stocks are often misunderstood to be risky and speculative. However, small-cap stocks are the best way for investors to get into the...

- Launched in April 2020, TelaRep allows doctors to text pharmaceutical representatives directly from within the electronic health record (EHR) platform - As part of OptimizeRx’s Therapy, Initiation and Persistence Platform, TelaRep is now being used by over 200,000 in-netw...

ROCHESTER, Mich., May 24, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the 42 ...

ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced that Mike Rousselle, vice president of data product...

OptimizeRx (NASDAQ:OPRX) has announced that its Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $20M of its outstanding common stock. Will Febbo, OptimizeRx CEO commented, "The share buyback program highlights the convictio...

ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously a...

ROCHESTER, Mich., May 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the RBC H...